MARGARET COSTELLO: Open Payments
NPI 1245566629 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,550 in 123 payments from 19 companies in 2025. Trend: 2023 $2,514 · 2024 $2,572 · 2025 $2,550
Food & beverage: $2,467Education: $83
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $340 |
| Novartis Pharmaceuticals Corporation | 11 | $316 |
| Galderma Laboratories, L.P. | 9 | $223 |
| UCB, Inc. | 10 | $208 |
| Janssen Biotech, Inc. | 7 | $199 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $167 |
| PFIZER INC. | 10 | $161 |
| Regeneron Healthcare Solutions, Inc. | 6 | $156 |
| Almirall LLC | 10 | $143 |
| LEO Pharma Inc. | 7 | $141 |
Products named: SKYRIZI, Bimzelx, TREMFYA, COSENTYX, DUPIXENT, NEMLUVIO, CIBINQO, ILUMYA.
Industry payments across MO — which companies pay providers there.
